This website sets cookies which are used to offer a personalized experience on our website, generate statistics, and realize advertising or social network tracking. Find out more about our Privacy & Cookie policy and how to manage them on your browser. You can change your cookie settings at any time.

Out of public health concerns and given the current travel restrictions and lab closures worldwide because of COVID-19, the 27th International Symposium on Hepatitis C Virus and Related Viruses (HCV2020), scheduled to take place July 6 – 9, 2020 in Montreal, Canada will be postponed.

hcv2020 newsroom


HCV2020 COVID-19 UPDATE

 
March 19, 2020 
 
Dear colleagues,
 
Out of public health concerns and given the current travel restrictions and lab closures worldwide because of COVID-19, the 27th International Symposium on Hepatitis C Virus and Related Viruses (HCV2020), scheduled to take place July 6 – 9, 2020 in Montreal, Canada will be postponed.
 
We are currently observing the global health situation and working on scheduling new dates to hold the meeting. More details will be announced in the next few weeks.
 
Current registrations remain valid for the new dates to be announced. However, if you prefer to cancel your registration and be fully refunded, please contact us at HCV2020Registration@mci-group.com.
 
We remain committed to providing an outstanding scientific and social programme and look forward to welcoming everyone to Montreal at a later date. If you have any questions or concerns, we invite you to contact us at HCV2020scientific_committee@mci-group.com.
 
Our thoughts and support go out to all those affected and our colleagues on the frontline dealing with this outbreak in various settings.
 
Stay safe and healthy.
 
Sincerely,
HCV 2020 Meeting Co-Chairs
 
Naglaa Shoukry, 
BPharm, PhD
Jordan Feld, MPH, 
MD
Daniel Lamarre, PhD

 

HCV2020 COVID-19 UPDATE | March 10, 2020

March 10, 2020
 
Dear colleagues,
 
We have been following closely the recent developments with COVID-19, the novel coronavirus. Our thoughts and support go out to all those affected and our colleagues on the frontline dealing with this outbreak in various settings.
 
We are committed to sharing updates with information about COVID-19’s potential impact on the 27th International Symposium on Hepatitis C Virus and Related Viruses (HCV2020), scheduled to take place July 6 – 9, 2020 in Montreal, Canada.
 
The risk within the Greater Montreal Area continues to be considered low by the authorities.
 
At this time, the symposium is moving forward as scheduled at this time. Early Bird registration, Abstract Submission and Travel Awards application will close on March 29, 2020. We are also exploring novel innovative options that would allow participation of colleagues who may not be able to attend in person because of travel restrictions or professional commitments due to COVID-19.
 
Given ongoing developments around COVID-19, we would like to assure you that measures have been taken into consideration, and we will continue to monitor the situation closely. We will take direction from the SANTÉ MONTRÉAL office as well as provincial and federal authorities, as required. For the most up-to-date and reliable information, please refer to official organizations, such as the World Health Organization(WHO)), and the Public Health Agency of Canada.
 
For travel guidelines and recommendations, please visit Travel Advice and Advisories
 
If you have any questions or concerns, we invite you to contact us at: hcv2020partnerships@mci-group.com
 
We look forward to welcoming everyone to the 27th International Symposium on Hepatitis C Virus and Related Viruses (HCV2020) in July in Montreal.
 
Sincerely,
Naglaa Shoukry, BPharm, PhD
Jordan Feld, MPH, MD
Daniel Lamarre, PhD
HCV 2020 Meeting Co-Chairs
Naglaa Shoukry, 
BPharm, PhD
Jordan Feld, MPH, 
MD
Daniel Lamarre, PhD

 


 

HARASSMENT POLICY

Latest update: February 9, 2020

The local organizing committee (LOC) of HCV2020 and the International organizing committee (IOC) of the “International Symposium on hepatitis C virus and related viruses” have a zero-tolerance policy towards harassment of any kind.

We are dedicated to providing an engaging and inclusive environment at the Symposia and any associated events including affiliated workshops, welcome receptions, and conference dinners. We expect positive, constructive and professional discussion, that values diversity and inclusion. No participant should be subjected to harassment of any kind when participating in our events.

For purposes of this policy, harassment means unwelcome and offensive comments made directly, indirectly or via social media or behaviour pertaining to the participant's sex, race, colour, national origin, religion, sexual orientation or gender identity, disability, or other status protected under applicable law. Harassment can include, for example, unwelcome attention, comments or jokes that focus on gender differences or sexual topics, and that distract from the professional topics under discussion, unwelcome advances or requests for dates or sexual activities, and the use of language or images that demean or degrade persons of particular gender, racial, ethnic, religious or national identity.

By registering for HCV2020, it is expected that participants will maintain these values and avoid harassment of others participating in our Symposia and associated events. Anyone who has experienced harassment, or who has witnessed such behaviour, should notify the Convenor of the Symposia and the chair of the IOC.  In the event that a registrant has made a formal complaint involving another registrant (outside the Symposia forum) and this complaint is active or proven, we ask that this is brought to the attention of the chair of the IOC with a request for recommended action. Such action may include that the complainee is excluded from participating in the Symposia.

Persons who act contrary to these values and expectations may be warned or asked to leave the event in which the behaviour occurred, and, maybe excluded from access to future Symposia.

Name

Role

Contact

Naglaa Shoukry

Convenor HCV2020

naglaa.shoukry@umontreal.ca

Brett Lindenbach

Chair IOC 2020-

Brett.lindenbach@yale.edu


 

EQUITY, DIVERSITY AND INCLUSION

The local organizing committee (LOC) of HCV2020 and the International organizing committee (IOC) of the “International Symposium on hepatitis C virus and related viruses” are committed to diversity, inclusiveness and equity and seek to prevent discrimination of any kind at its Symposia and related events. This includes ensuring appropriate inclusion within the program and consideration towards people of different ethnicity, genders, and career stage at its symposia and related events.